Document:EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot) Β |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{DocumentData | |||
Β | |||
Β | |||
|reference=EUΒ EMA/INS/GCP/126568/2023 | |reference=EUΒ EMA/INS/GCP/126568/2023 | ||
- | - | ||
| Line 51: | Line 25: | ||
|contributors= | |contributors= | ||
}} | }} | ||
Latest revision as of 14:15, 16 July 2026
| Document information | |
|---|---|
| Reference | EU EMA/INS/GCP/126568/2023
- Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 |
| Validity area | EU |
| Scope(s) | G |
| Document name | EMA/INS/GCP/126568/2023
- Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 |
| Version / Revision | 2023 |
| Status | Current |
| Document type | Official guideline |
| Language(s) | EN |
| Description | EMA/INS/GCP/164938/2024
Inspections Office Quality and Safety of Medicines Department Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2023 Adopted by the GCP IWG on 26 November 2024 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 a) | G | 3.1.2 a) | EN | 3.1.2. Categorisation of findings
a) General overview A total of 470 deficiencies, comprising 17 critical (3.6%), 260 major (55.3%) and 193 minor (41.β¦ |
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - ComCompliance | G | 3.1.2 - ComCompliance | EN | Examples of critical and major findings in the sub-categories of the three main categories "General", "Trial Management", and "Investigational Site" a⦠|
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Monitoring | G | 3.1.2 - Monitoring | EN | Examples of critical and major findings in the sub-categories of the three main categories "General", "Trial Management", and "Investigational Site" a⦠|
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Organisation | G | 3.1.2 - Organisation | EN | Examples of critical and major findings in the sub-categories of the three main categories "General", "Trial Management", and "Investigational Site" a⦠|
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Randomisation | G | 3.1.2 - Randomisation | EN | Examples of critical and major findings in the sub-categories of the three main categories "General", "Trial Management", and "Investigational Site" a⦠|
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - SD | G | 3.1.2 - SD | EN | Examples of critical and major findings in the sub-categories of the three main categories "General", "Trial Management", and "Investigational Site" a⦠|
| EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 4.3 | G | 4.3 | EN | 4.3. Inspection cooperation
⒠Cooperation between the EU/EEA MSs: Nearly all the inspections conducted in 2022 were joint inspections involving inspe⦠|
